Charlie Sheen has credited an experimental anti-HIV drug for helping him ward off borderline dementia, throwing his star power behind the dose in an effort to help get it approved for wider use.
The actor spoke at an awareness contest in Hollywood last darknes for PRO 140, an injectable therapy for HIV patients being marketed by Vancouver, Wash.-based biotechnology firm CytoDyn.
Sheen, who revealed that he was HIV positive in November 2015, told the crowd of 300 gather together the Hollywood Roosevelt that he was previously taking four pills daily as part of his cocktail of drugs, but suffered from serious side effects as a result.[ The stimulants] deter me stifled and alive, he suggested, but I strove with a constant migraine and at times, borderline dementia.
Sheen was first introduced to PRO 140 on the Dr. Oz show last-place February, when CytoDyns CEO appeared on the orator to offer to enroll the actor into a clinical contest of the injectable drug.